燃石医学乳腺癌NGS试剂盒进入药监局优先审批通道

Core Viewpoint - The breast cancer NGS companion diagnostic kit developed by the company has entered the priority review channel of the National Medical Products Administration (NMPA), which will shorten the approval cycle for the product in China [1]. Product Development Progress - The entry of the diagnostic kit into the priority review channel is a significant technological advancement worth noting [2].